Company
Superluminal Medicines
https://www.superluminalrx.com/
| Industry | biotechnology company integrating AI/ML, protein dynamics, and structural biology to generate G protein-coupled receptor (GPCR) targets |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Superluminal Medicines | Series B | 2026-09-03 |
| Superluminal Medicines | Seed Funding | 2023-09-04 |